Published by Iain Gilbert on 6th August 2026
(Sharecast News) - Drugmaker Hikma Pharmaceuticals turned in a solid first half on Thursday, with group revenues rising 4% to $1.73bn, driven by a strong performance in its branded unit and stable contributions from both injectables and Hikma Rx.
URL: http://www.digitallook.com/dl/news/story/36123047/...